{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:29:48Z","timestamp":1790638188548,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bcp.2024.116400","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T13:45:02Z","timestamp":1719582302000},"page":"116400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Tackling multi-drug resistant fungi by efflux pump inhibitors"],"prefix":"10.1016","volume":"226","author":[{"given":"Kritika","family":"Engle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-1416","authenticated-orcid":false,"given":"Gautam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116400_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: A wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bcp.2024.116400_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.20411\/pai.v3i2.249","article-title":"Fungal Diseases in the 21st Century: The Near and Far Horizons","volume":"3","author":"Casadevall","year":"2018","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.bcp.2024.116400_b0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses."},{"key":"10.1016\/j.bcp.2024.116400_b0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/13543776.2016.1146693","article-title":"Antifungal drugs combinations: A patent review 2000\u20132015","volume":"26","author":"Svetaz","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2024.116400_b0025","doi-asserted-by":"crossref","first-page":"ii27","DOI":"10.1093\/jac\/dkz041","article-title":"Diagnosis and treatment of invasive fungal infections: looking ahead","volume":"74","author":"Sanguinetti","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections, in","author":"Enoch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0035","first-page":"271","article-title":"Invasive Fungal Infection","volume":"116","author":"von Lilienfeld-Toal","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.bcp.2024.116400_b0040","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1039\/C9CS00556K","article-title":"A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise","volume":"49","author":"Howard","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2024.116400_b0045","doi-asserted-by":"crossref","unstructured":"N. Robbins, G.D. Wright, L.E. Cowen, Antifungal Drugs: The Current Armamentarium and Development of New Agents, in: The Fungal Kingdom, ASM Press, Washington, DC, USA, 2017: pp. 903\u2013922. doi:10.1128\/9781555819583.ch44.","DOI":"10.1128\/9781555819583.ch44"},{"key":"10.1016\/j.bcp.2024.116400_b0050","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging New Targets for the Treatment of Resistant Fungal Infections","volume":"61","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116400_b0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4155\/tde-2023-0076","article-title":"Microemulsions, nanoemulsions and emulgels as carriers for antifungal antibiotics","volume":"14","author":"Padaraju","year":"2023","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bcp.2024.116400_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13739","article-title":"New pathogens, new tricks: emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics","volume":"1435","author":"Geddes-McAlister","year":"2019","journal-title":"Ann. n. y. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116400_b0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/antibiotics9120877","article-title":"Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium","volume":"9","author":"Arastehfar","year":"2020","journal-title":"Antibiotics."},{"key":"10.1016\/j.bcp.2024.116400_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic approaches to treatment of fungal diseases","volume":"17","author":"Armstrong-James","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bcp.2024.116400_b0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on Antifungal Drug Resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr. Clin. Microbiol. Reports."},{"key":"10.1016\/j.bcp.2024.116400_b0080","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.jmedchem.6b01203","article-title":"Tackling Fungal Resistance by Biofilm Inhibitors","volume":"60","author":"Wu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116400_b0085","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bcp.2024.116400_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcp.2024.116400_b0095","doi-asserted-by":"crossref","unstructured":"R. Prasad, A.H. Shah, M.K. Rawal, Antifungals: Mechanism of Action and Drug Resistance, in: Adv. Exp. Med. Biol., 2016: pp. 327\u2013349. doi:10.1007\/978-3-319-25304-6_14.","DOI":"10.1007\/978-3-319-25304-6_14"},{"key":"10.1016\/j.bcp.2024.116400_b0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dkz400","article-title":"Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus candida albicans","volume":"75","author":"Nishimoto","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8101574","article-title":"Mitochondria-Mediated Azole Drug Resistance and Fungal Pathogenicity: Opportunities for Therapeutic Development","volume":"8","author":"Song","year":"2020","journal-title":"Microorganisms."},{"key":"10.1016\/j.bcp.2024.116400_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01839-20","article-title":"The C 2 H 2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target","volume":"65","author":"Du","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/lam.12820","article-title":"Antifungals discovery: an insight into new strategies to combat antifungal resistance","volume":"66","author":"Fuentefria","year":"2018","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-019-0702-9","article-title":"Antifungal Resistance: a Concerning Trend for the Present and Future","volume":"21","author":"Hendrickson","year":"2019","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2016.06.007","article-title":"Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials","volume":"28","author":"Hernando-Amado","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2024.116400_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update","volume":"239","author":"Engle","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116400_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance","volume":"5","author":"Prasad","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116400_b0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fgb.2009.08.002","article-title":"Regulation of multidrug resistance in pathogenic fungi","volume":"47","author":"Morschh\u00e4user","year":"2010","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0145","doi-asserted-by":"crossref","unstructured":"C. Costa, P.J. Dias, I. S\u00e1-Correia, M.C. Teixeira, MFS multidrug transporters in pathogenic fungi: Do they have real clinical impact?, Front. Physiol. 5 MAY (2014) 1\u20138. doi:10.3389\/fphys.2014.00197.","DOI":"10.3389\/fphys.2014.00197"},{"key":"10.1016\/j.bcp.2024.116400_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2020.126684","article-title":"An update on ABC transporters of filamentous fungi \u2013 from physiological substrates to xenobiotics","volume":"246","author":"V\u00edgla\u0161","year":"2021","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bcp.2024.116400_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fgb.2021.103550","article-title":"Multiple roles of ABC transporters in yeast","volume":"150","author":"Kumari","year":"2021","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14728222.2017.1265105","article-title":"Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors","volume":"21","author":"Willers","year":"2017","journal-title":"Expert Opin. Ther. Targets."},{"key":"10.1016\/j.bcp.2024.116400_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01022-18","article-title":"Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps","volume":"62","author":"Paul","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0170","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/jac\/dkw252","article-title":"Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension","volume":"71","author":"Tsao","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0175","doi-asserted-by":"crossref","unstructured":"R. Prasad, M.K. Rawal, A.H. Shah, Candida Efflux ATPases and Antiporters in Clinical Drug Resistance, in: Adv. Exp. Med. Biol., 2016: pp. 351\u2013376. doi:10.1007\/978-3-319-25304-6_15.","DOI":"10.1007\/978-3-319-25304-6_15"},{"key":"10.1016\/j.bcp.2024.116400_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01751-17","article-title":"Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment","volume":"62","author":"Chang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fgb.2013.09.005","article-title":"Functional characterization of the hexose transporter Hxt13p: An efflux pump that mediates resistance to miltefosine in yeast","volume":"61","author":"Biswas","year":"2013","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-Mediated Antifungal Drug Resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bcp.2024.116400_b0195","first-page":"367","article-title":"Outwitting Multidrug Resistance to Antifungals, Science (80-","volume":"321","author":"Monk","year":"2008","journal-title":")"},{"key":"10.1016\/j.bcp.2024.116400_b0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature16963","article-title":"Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction","volume":"530","author":"Nishikawa","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.bcp.2024.116400_b0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/1469-0691.12495","article-title":"Antifungal drug resistance mechanisms in pathogenic fungi: From bench to bedside","volume":"20","author":"Cuenca-Estrella","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bcp.2024.116400_b0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12275-016-5628-4","article-title":"The development of fluconazole resistance in Candida albicans \u2013 an example of microevolution of a fungal pathogen","volume":"54","author":"Morschh\u00e4user","year":"2016","journal-title":"J. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0215","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1128\/AAC.00344-11","article-title":"The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans","volume":"55","author":"Sharma","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.fgb.2009.10.007","article-title":"Fungal PDR transporters: Phylogeny, topology, motifs and function","volume":"47","author":"Lamping","year":"2010","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0924-8579(03)00213-9","article-title":"Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast","volume":"22","author":"Schuetzer-Muehlbauer","year":"2003","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bcp.2024.116400_b0230","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00203-015-1146-8","article-title":"ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates","volume":"197","author":"Xu","year":"2015","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0235","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/mdr.2016.0095","article-title":"Mutations and\/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans","volume":"23","author":"Feng","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.bcp.2024.116400_b0240","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1128\/AAC.00925-15","article-title":"Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14\u03b1-Demethylase","volume":"59","author":"Sagatova","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-3-319-25304-6_15","article-title":"Candida efflux ATPases and antiporters in clinical drug resistance","volume":"892","author":"Prasad","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"47","author":"Walker","year":"2010","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2022.120391","article-title":"Microbial resistance: The role of efflux pump superfamilies and their respective substrates","volume":"295","author":"Garcia","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2024.116400_b0265","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","article-title":"Molecular mechanisms of primary resistance to flucytosine in Candida albicans","volume":"48","author":"Hope","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ddtec.2014.02.005","article-title":"Overcoming antifungal resistance","volume":"11","author":"Srinivasan","year":"2014","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bcp.2024.116400_b0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","article-title":"The modification of natural products for medical use","volume":"7","author":"Guo","year":"2017","journal-title":"Acta Pharm. Sin. b."},{"key":"10.1016\/j.bcp.2024.116400_b0280","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1039\/D2NP00084A","article-title":"Natural products acting against S. aureus through membrane and cell wall disruption","volume":"40","author":"Kumar","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0285","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.drudis.2016.11.015","article-title":"Recent developments in natural product-based drug discovery for tuberculosis","volume":"22","author":"Dong","year":"2017","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bcp.2024.116400_b0290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.copbio.2021.02.001","article-title":"Antifungal natural products","volume":"69","author":"Heard","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bcp.2024.116400_b0295","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","article-title":"Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p","volume":"66","author":"Tong","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.bcp.2024.116400_b0300","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jgar.2020.04.013","article-title":"Octyl gallate reduces ABC multidrug transporter CaCdr1p expression and leads to its mislocalisation in azole-resistant clinical isolates of Candida albicans","volume":"22","author":"Singh","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bcp.2024.116400_b0305","first-page":"1","article-title":"Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans","author":"Xie","year":"2016","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.bcp.2024.116400_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/aac.02126-21","article-title":"Palmarumycin P3 Reverses Mrr1-Mediated Azole Resistance by Blocking the Efflux Pump Mdr1","volume":"66","author":"Song","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0315","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/acs.jnatprod.5b00998","article-title":"Heptaketides from an Endolichenic Fungus Biatriospora sp. and Their Antifungal Activity","volume":"79","author":"Zhou","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bcp.2024.116400_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10050537","article-title":"Involvement of a multidrug efflux pump and alterations in cell surface structure in the synergistic antifungal activity of nagilactone e and anethole against budding yeast saccharomyces cerevisiae","volume":"10","author":"Ueda","year":"2021","journal-title":"Antibiotics."},{"key":"10.1016\/j.bcp.2024.116400_b0325","doi-asserted-by":"crossref","unstructured":"K. ichi Fujita, T. Ishikura, Y. Jono, Y. Yamaguchi, A. Ogita, I. Kubo, T. Tanaka, Anethole potentiates dodecanol\u2019s fungicidal activity by reducing PDR5 expression in budding yeast, Biochim. Biophys. Acta - Gen. Subj. 1861 (2017) 477\u2013484. doi:10.1016\/j.bbagen.2016.09.010.","DOI":"10.1016\/j.bbagen.2016.09.010"},{"key":"10.1016\/j.bcp.2024.116400_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00211","article-title":"Eucalyptal D enhances the antifungal effect of fluconazole on fluconazole-resistant candida albicans by competitively inhibiting efflux pump","volume":"9","author":"Xu","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0335","first-page":"1","article-title":"Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism","volume":"13","author":"Singh","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2024.116400_b0340","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1007\/s00253-021-11397-6","article-title":"Geraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways","volume":"105","author":"Gupta","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bcp.2024.116400_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02892","article-title":"Strong Synergism of Palmatine and Fluconazole\/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.01525","article-title":"Antifungal Activity of the Natural Coumarin Scopoletin Against Planktonic Cells and Biofilms From a Multidrug-Resistant Candida tropicalis Strain","volume":"11","author":"Lemos","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2019.100921","article-title":"Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux","volume":"30","author":"Saibabu","year":"2020","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.bcp.2024.116400_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111568","article-title":"Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans","volume":"139","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116400_b0365","first-page":"199","article-title":"Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans","volume":"32","author":"Yang","year":"2019","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.bcp.2024.116400_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0934-7","article-title":"Isolation and characterization of an antifungal compound 5-hydroxy-7,4\u2019-dimethoxyflavone from Combretum zeyheri","volume":"15","author":"Mangoyi","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bcp.2024.116400_b0375","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1007\/s11033-019-05020-1","article-title":"The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis","volume":"46","author":"Zhao","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0380","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/mdr.2016.0217","article-title":"Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus","volume":"23","author":"Li","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.bcp.2024.116400_b0385","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1055\/s-0042-106169","article-title":"Overcoming Multidrug Resistance in Candida albicans: Macrocyclic Diterpenes from Euphorbia Species as Potent Inhibitors of Drug Efflux Pumps","volume":"82","author":"Nim","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.bcp.2024.116400_b0390","doi-asserted-by":"crossref","unstructured":"T. Fukada, M. Arai, H. Tomoda, S. \u00d5mura, New beauvericins, potentiators of antifungal miconazole activity, produced by Beauveria sp. FKI-1366. II. Structure elucidation, J. Antibiot. (Tokyo). 57 (2004) 117\u2013124. doi:10.7164\/antibiotics.57.117.","DOI":"10.7164\/antibiotics.57.117"},{"key":"10.1016\/j.bcp.2024.116400_b0395","first-page":"158","article-title":"Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters, Synth. Syst","volume":"1","author":"Tong","year":"2016","journal-title":"Biotechnol."},{"key":"10.1016\/j.bcp.2024.116400_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110580","article-title":"The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation","volume":"130","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116400_b0405","first-page":"3278","article-title":"Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model, Bioorganic","volume":"25","author":"M\u00f3nico","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bcp.2024.116400_b0410","first-page":"272","article-title":"Linalool modulates dermatophyte susceptibility to azole drugs","volume":"58","author":"Ponte","year":"2020","journal-title":"Med. Mycol."},{"key":"10.1016\/j.bcp.2024.116400_b0415","article-title":"SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsyr\/fov001","article-title":"Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans","volume":"15","author":"Li","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.bcp.2024.116400_b0425","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jam.12737","article-title":"Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans","volume":"118","author":"Sun","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0430","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/mdr.2017.0332","article-title":"Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans","volume":"25","author":"\u010cern\u00e1kov\u00e1","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.bcp.2024.116400_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/jof8080783","article-title":"Farnesol Boosts the Antifungal Effect of Fluconazole and Modulates Resistance in Candida auris through Regulation of the CDR1 and ERG11 Genes","volume":"8","author":"Dekkerov\u00e1","year":"2022","journal-title":"J. Fungi."},{"key":"10.1016\/j.bcp.2024.116400_b0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/lam.13083","article-title":"Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast","volume":"68","author":"Yamawaki","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0445","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/jam.14870","article-title":"Antifungal and anti-biofilm effects of 6-shogaol against Candida auris","volume":"130","author":"Kim","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0450","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3109\/13880209.2015.1091483","article-title":"The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans","volume":"54","author":"Shao","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0455","first-page":"1436","article-title":"Revealing the astragalin mode of anticandidal action","volume":"19","author":"Ivanov","year":"2020","journal-title":"EXCLI J."},{"key":"10.1016\/j.bcp.2024.116400_b0460","first-page":"209","article-title":"Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation","volume":"17","author":"Shi","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bcp.2024.116400_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106030","article-title":"The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms","volume":"56","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bcp.2024.116400_b0470","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgar.2020.10.025","article-title":"Reversal of azole resistance in Candida albicans by oridonin","volume":"24","author":"Chen","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bcp.2024.116400_b0475","doi-asserted-by":"crossref","unstructured":"D.C. de Moraes, K.M. Cardoso, L.T.S. Domingos, M. do Carmo Freire Ribeiro Pinto, R.Q. Monteiro, A. Ferreira-Pereira, \u03b2-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain, Brazilian J. Microbiol. 51 (2020) 1051\u20131060. doi:10.1007\/s42770-020-00254-9.","DOI":"10.1007\/s42770-020-00254-9"},{"key":"10.1016\/j.bcp.2024.116400_b0480","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00100-21","article-title":"Pyrogallol and fluconazole interact synergistically in vitro against candida glabrata through an efflux-associated mechanism","volume":"65","author":"Yao","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0485","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5989206","article-title":"Antifungal Activity of Thai Cajuput Oil and Its Effect on Efflux-Pump Gene Expression in Fluconazole-Resistant Candida albicans Clinical Isolates","volume":"2020","author":"Keereedach","year":"2020","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0490","first-page":"1","article-title":"Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1","volume":"4","author":"Gil","year":"1851","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.bcp.2024.116400_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/jof8050521","article-title":"Encephalartos villosus Lem. Displays a Strong In Vivo and In Vitro Antifungal Potential against Candida glabrata Clinical Isolates","volume":"8","author":"Alqahtani","year":"2022","journal-title":"J. Fungi."},{"key":"10.1016\/j.bcp.2024.116400_b0500","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1139\/cjm-2019-0491","article-title":"Lactobacillus rhamnosus cell-free extract targets virulence and antifungal drug resistance in candida albicans","volume":"66","author":"Dube","year":"2020","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0505","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.drudis.2022.04.021","article-title":"Repurposing and optimization of drugs for discovery of novel antifungals","volume":"27","author":"Donlin","year":"2022","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bcp.2024.116400_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/mps2020031","article-title":"High Efficiency Drug Repurposing Design for New Antifungal Agents","volume":"2","author":"Kim","year":"2019","journal-title":"Methods Protoc."},{"key":"10.1016\/j.bcp.2024.116400_b0515","doi-asserted-by":"crossref","unstructured":"I.R.G. Capoci, D.R. Faria, K.M. Sakita, F.A.V. Rodrigues-Vendramini, P. de S. Bonfim-Mendon\u00e7a, T.C.A. Becker, \u00c9.S. Kioshima, T.I.E. Svidzinski, B. Maigret, Repurposing approach identifies new treatment options for invasive fungal disease, Bioorg. Chem. 84 (2019) 87\u201397. doi:10.1016\/j.bioorg.2018.11.019.","DOI":"10.1016\/j.bioorg.2018.11.019"},{"key":"10.1016\/j.bcp.2024.116400_b0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2017.07.030","article-title":"Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections","volume":"139","author":"Holbrook","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116400_b0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01084-18","article-title":"Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development","volume":"62","author":"Wall","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0530","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/14656566.2016.1186647","article-title":"Can repurposing of existing drugs provide more effective therapies for invasive fungal infections?","volume":"17","author":"Katragkou","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116400_b0535","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence."},{"key":"10.1016\/j.bcp.2024.116400_b0540","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijantimicag.2017.03.015","article-title":"Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence","volume":"50","author":"Sun","year":"2017","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bcp.2024.116400_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168936","article-title":"Synergistic effects and mechanisms of budesonide in combination with fluconazole against resistant candida albicans","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2024.116400_b0550","first-page":"1","article-title":"Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2024.116400_b0555","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2012.10.009","article-title":"In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms","volume":"41","author":"Yu","year":"2013","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bcp.2024.116400_b0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/21505594.2020.1868814","article-title":"Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella","volume":"12","author":"Vega-Chac\u00f3n","year":"2021","journal-title":"Virulence."},{"key":"10.1016\/j.bcp.2024.116400_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.576975","article-title":"In vitro and in vivo Study of Antifungal Effect of Pyrvinium Pamoate Alone and in Combination With Azoles Against Exophiala dermatitidis","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0570","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116400_b0575","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03414-3","article-title":"The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer","volume":"12","author":"Eyermann","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116400_b0580","first-page":"1","article-title":"Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0585","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.50.2.414-421.2006","article-title":"Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis","volume":"50","author":"Widmer","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0590","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1128\/AAC.01890-15","article-title":"In vitro activity of miltefosine against Candida albicans under planktonic and biofilm growth conditions and in vivo efficacy in a murine model of oral candidiasis","volume":"59","author":"Vila","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2024.116400_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2023.106819","article-title":"Miltefosine exhibits fungicidal activity through oxidative stress generation and Aif1 activation in Candida albicans","volume":"62","author":"Wu","year":"2023","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bcp.2024.116400_b0600","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1751-7915.13814","article-title":"Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species","volume":"15","author":"Liu","year":"2022","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.bcp.2024.116400_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62976-y","article-title":"Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities","volume":"10","author":"Eldesouky","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/13543776.2020.1704733","article-title":"Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors","volume":"30","author":"Spugnini","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2024.116400_b0615","first-page":"1","article-title":"Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans","volume":"10","author":"Lu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0620","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.bmcl.2017.05.010","article-title":"Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-\u03b2-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease, Bioorganic Med","volume":"27","author":"Bi","year":"2017","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bcp.2024.116400_b0625","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10123-021-00203-y","article-title":"Anti-infective properties of proton pump inhibitors: perspectives","volume":"25","author":"da Rosa","year":"2022","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0630","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00280-017-3426-2","article-title":"Repositioning of proton pump inhibitors in cancer therapy","volume":"80","author":"Lu","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116400_b0635","first-page":"279","article-title":"Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis","volume":"185","author":"Aneke","year":"2020","journal-title":"Mycopathologia."},{"key":"10.1016\/j.bcp.2024.116400_b0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsps.2022.01.011","article-title":"Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates","volume":"30","author":"El-Ganiny","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bcp.2024.116400_b0645","doi-asserted-by":"crossref","unstructured":"M. Lu, C. Yu, X. Cui, J. Shi, L. Yuan, S. Sun, Gentamicin synergises with azoles against drug-resistant Candida albicans, Elsevier B.V., 2018. doi:10.1016\/j.ijantimicag.2017.09.012.","DOI":"10.1016\/j.ijantimicag.2017.09.012"},{"key":"10.1016\/j.bcp.2024.116400_b0650","first-page":"1","article-title":"The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms","author":"Jia","year":"2016","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bcp.2024.116400_b0655","first-page":"1","article-title":"Poloxamer-enhanced solubility of griseofulvin and its related antifungal activity against Trichophyton spp., Brazilian","volume":"58","author":"Pittol","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2024.116400_b0660","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1038\/s41598-021-87243-6","article-title":"Solubility of Ketoconazole (antifungal drug) in SC-CO2 for binary and ternary systems: measurements and empirical correlations","volume":"11","author":"Sodeifian","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116400_b0665","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molliq.2018.02.068","article-title":"Measurement and correlation of clotrimazole solubility in ethanol + water mixtures at T = (293.2 to 313.2) K","volume":"256","author":"Saadatfar","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bcp.2024.116400_b0670","first-page":"182","article-title":"Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging","volume":"14","author":"Han","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bcp.2024.116400_b0675","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.colsurfa.2018.08.082","article-title":"Improved delivery of voriconazole to Aspergillus fumigatus through solid lipid nanoparticles as an effective carrier","volume":"558","author":"Kelidari","year":"2018","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bcp.2024.116400_b0680","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijbiomac.2019.09.036","article-title":"Augmented control of drug-resistant Candida spp. via fluconazole loading into fungal chitosan nanoparticles","volume":"141","author":"El Rabey","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2024.116400_b0685","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.colsurfb.2016.03.013","article-title":"Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system","volume":"142","author":"Moazeni","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.bcp.2024.116400_b0690","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12668-017-0481-4","article-title":"Green Synthesis of Silver Nanoparticles and their Antifungal Properties","volume":"8","author":"Prasher","year":"2018","journal-title":"Bionanoscience."},{"key":"10.1016\/j.bcp.2024.116400_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2021.104937","article-title":"Silver nanoparticles offer a synergistic effect with fluconazole against fluconazole-resistant Candida albicans by abrogating drug efflux pumps and increasing endogenous ROS","volume":"93","author":"Jia","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bcp.2024.116400_b0700","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jddst.2018.11.023","article-title":"Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery","volume":"49","author":"Deshkar","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bcp.2024.116400_b0705","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.apsb.2021.03.030","article-title":"Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm. Sin. b."},{"key":"10.1016\/j.bcp.2024.116400_b0710","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2015.08.088","article-title":"Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole","volume":"495","author":"Kakkar","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2024.116400_b0715","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2017.02.008","article-title":"Improved yeast delivery of fluconazole with a nanostructured lipid carrier system","volume":"89","author":"Kelidari","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116400_b0720","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1166\/jnn.2016.10934","article-title":"Synergy between polyvinylpyrrolidone-coated silver nanoparticles and azole antifungal against drug-resistant Candida albicans","volume":"16","author":"Sun","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bcp.2024.116400_b0725","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.ica.2007.03.033","article-title":"Synthesis, crystal structures and in vitro anti-fungal activities of two silver(I) coordination polymers with fluconazole","volume":"360","author":"Zhang","year":"2007","journal-title":"Inorganica Chim. Acta."},{"key":"10.1016\/j.bcp.2024.116400_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128229","article-title":"Synthesis, crystal structure and in vitro antifungal activity of two-dimensional silver(I)-voriconazole coordination complexes","volume":"1215","author":"Ou","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bcp.2024.116400_b0735","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/IDR.S164262","article-title":"Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates","volume":"11","author":"de Alteriis","year":"2018","journal-title":"Infect. Drug Resist."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T20:12:43Z","timestamp":1728331963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224003836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":147,"alternative-id":["S0006295224003836"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116400","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling multi-drug resistant fungi by efflux pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116400"}}